Structure | Chemical Name | CAS | MF |
|
1-Aziridinecarboxylicacid,2-methyl-,1-methylethylester(9CI)
|
170116-58-2
|
C7H13NO2
|
|
Z-PRO-PRO-ALDEHYDE-DIMETHYL ACETAL
|
170116-63-9
|
C20H28N2O5
|
|
2-Cyclobuten-1-one,2,3,4-triethoxy-4-methyl-(9CI)
|
170117-93-8
|
C11H18O4
|
|
2-Cyclobuten-1-one,3,4-diethoxy-2-methyl-4-(2-propenyl)-(9CI)
|
170117-99-4
|
C12H18O3
|
|
Bicyclo[3.2.0]hept-3-en-6-one, 3,4-diethoxy-5-methyl- (9CI)
|
170118-01-1
|
C12H18O3
|
|
1-ETHOXY-4,4,5,5,5-PENTAFLUORO-PENT-1-EN-3-ONE
|
170118-60-2
|
C7H7F5O2
|
|
[1-(4-CHLORO-PHENYL)-2-PYRROLIDIN-1-YL-ETHYL]-METHYL-AMINE
|
170119-33-2
|
C13H19ClN2
|
|
2-(methoxycarbonylamino)-2-(4-methoxyphenyl)acetic acid
|
170119-36-5
|
C11H13NO5
|
|
Ethyl N-Boc-3-oxopyrrolidine-2-carboxylate
|
170123-25-8
|
C12H19NO5
|
|
2-Cyclohexen-1-one,4-hydroxy-5-methyl-2-(1-methylethyl)-,trans-(-)-(9CI)
|
170127-86-3
|
C10H16O2
|
|
3-OXETANECARBONITRILE, 3-METHYL-
|
170128-14-0
|
C5H7NO
|
|
PHOSPHOLIPID PTC (cocamidopropyl pg-dimonium chloride phosphate)
|
170137-14-1
|
|
|
HUMAN MIDKINE
|
170138-17-7
|
|
|
OSH45 protein
|
170138-61-1
|
|
|
2-Propen-1-one,3-(dimethylamino)-1-(3-ethoxyphenyl)-(9CI)
|
170140-82-6
|
C13H17NO2
|
|
3'-(TRIFLUOROMETHOXY)ACETOPHENONE
|
170141-63-6
|
C9H7F3O2
|
|
ZD 9379
|
170142-20-8
|
C19H14ClN3O4
|
|
3-METHYL HYDROGEN 7-CHLORO-1,4-DIHYDRO-4-OXOQUINOLINE-2,3-DICARBOXYLATE
|
170143-39-2
|
C12H8ClNO5
|
|
Hydrazine, (4-methoxy-2-methylphenyl)- (9CI)
|
170143-40-5
|
C8H12N2O
|
|
tert-Butyl 5-(benzyloxy)-1H-indole-1-carboxylate
|
170147-29-2
|
C20H21NO3
|
|
N-BOC-5-HYDROXYINDOLINE
|
170147-76-9
|
C13H17NO3
|
|
3(2H)-Pyridazinethione,6-amino-2-methyl-(9CI)
|
170149-21-0
|
C5H7N3S
|
|
4,5-Isoxazoledione,3-(methoxymethyl)-,4-oxime(9CI)
|
170149-34-5
|
C5H6N2O4
|
|
1,2,5-Oxadiazole-3-carboxamide,4-(aminomethyl)-,5-oxide(9CI)
|
170149-38-9
|
C4H6N4O3
|
|
1,2,5-Oxadiazole-3-carboxamide,4-(aminomethyl)-,2-oxide(9CI)
|
170149-39-0
|
C4H6N4O3
|
|
Nepicastat hydrochloride
|
170151-24-3
|
C14H16ClF2N3S
|
|
NEPICASTAT
|
170151-25-4
|
C14H15F2N3S
|
|
5,7-DIFLUORO-B-(S)-AMINOTETRALINE
|
170151-28-7
|
C10H11F2N
|
|
2-(3,4-Difluoro-phenyl)-benzothiazole
|
170151-90-3
|
C13H7F2NS
|
|
3-(2-([7-([3-(3-HYDROXY-3-OXOPROPYL)-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]METHYL)-4,4A,5,6-TETRAHYDRO-2(3H)-NAPHTHALENYLIDENE]METHYL)-1,3-BENZOTHIAZOL-3-IUM-3-YL)PROPANOATE
|
170153-80-7
|
C32H30N2O4S2
|
|
acyline
|
170157-13-8
|
C80H102ClN15O14
|
|
3-amino-N-[(1,1-dimethylethoxy)carbonyl]- L-Phenylalanine
|
170157-55-8
|
C14H20N2O4
|
|
BOC-L-4-AMINOMETHYLPHENYLALANINE(FMOC)
|
170157-61-6
|
C30H32N2O6
|
|
BOC-BETA-(2-QUINOLYL)-D-ALA-OH
|
170157-64-9
|
C17H20N2O4
|
|
1,4,8-Tri-Boc-1,4,8,11-tetraazacyclotetradecane
|
170161-27-0
|
C25H48N4O6
|
|
Ethanone, 1-(6-ethoxy-5,6-dihydro-2-methyl-1,4-oxathiin-3-yl)-, (R)- (9CI)
|
170161-58-7
|
C9H14O3S
|
|
Ethanone, 1-(6-ethoxy-5,6-dihydro-2-methyl-4-oxido-1,4-oxathiin-3-yl)- (9CI)
|
170161-60-1
|
C9H14O4S
|
|
N-(3-Chlorophenyl)-N-(4-nitrophenyl)aniline
|
170162-35-3
|
C18H13ClN2O2
|
|
1-Piperidinecarboxylic acid, 3-(aMinocarbonyl)-, 1,1-diMethylethyl ester, (3R)-
|
170164-46-2
|
C10H19N3O3
|
|
(S)-tert-Butyl 3-carbaMoylpiperazine-1-carboxylate
|
170164-47-3
|
C10H19N3O3
|
|
4-(2,4,5-tripyridin-4-ylphenyl)pyridine
|
170165-81-8
|
C26H18N4
|
|
1,3,5-tris(4-pyridyl)benzene
|
170165-84-1
|
C21H15N3
|
|
4,4'-(5'-(4-(pyridin-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)dipyridine
|
170165-85-2
|
C39H27N3
|
|
Acetic acid, 2-(3-methyl-5-isoxazolyl)hydrazide (9CI)
|
170167-61-0
|
C6H9N3O2
|
|
Hydrazinecarboxaldehyde, 2-(1,3-dimethyl-1H-pyrazol-5-yl)- (9CI)
|
170167-69-8
|
C6H10N4O
|
|
3-Furancarbonitrile,2-amino-4-ethyl-(9CI)
|
170170-12-4
|
C7H8N2O
|
|
5-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE-2,4-DIAMINE
|
170170-13-5
|
C7H9N5
|
|
Acetic acid, methoxy[(1-oxopropyl)amino]-, methyl ester (9CI)
|
170170-62-4
|
C7H13NO4
|
|
N-Desmethyl-4hydroxy Tamoxifen
|
170171-12-7
|
C25H27NO2
|
|
2 , 5-DIBROMO-4-METHYLTHIAZOLE
|
170172-38-0
|
C4H3Br2NS
|
|
Oxiranecarboxylicacid,trimethyl-,ethylester,(S)-(9CI)
|
170210-32-9
|
C8H14O3
|
|
Ketoconazole Impurity 4
|
170210-39-6
|
C18H15BrCl2O4
|
|
Ketoconazole Impurity 9 (Ketoconazole Hydroxymethyl Impurity)
|
170210-42-1
|
C14H14Cl2N2O3
|
|
Ketoconazole Impurity 3
|
170210-49-8
|
C14H14Cl2N2O3
|
|
(2S-CIS)-2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLANE-4-METHANOL, METHANESULFONATE (ESTER)KETOCONAZOLE
|
170210-50-1
|
C15H16Cl2N2O5S
|
|
(3R,5R)-1-Benzyl-3,5-dimethylpiperazine
|
170211-03-7
|
C13H20N2
|
|
C6NBD-Sphingosine,beta-D-galactosyl
|
170212-26-7
|
C36H59N5O11
|
|
N-[2-(4-METHOXYPHENYL)ETHYL]-METHANESULFONAMIDE
|
170215-60-8
|
C10H15NO3S
|
|
N,N-DIMETHYL-HIS-OME
|
170227-64-2
|
C9H15N3O2
|
|
3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECANE-9-CARBOXYLIC ACID
|
170228-81-6
|
C16H27NO4
|
|
1-METHYL-5-PHENYL-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE
|
170229-03-5
|
C16H16N2O
|
|
TERT-BUTYL 4,4-BIS(2-HYDROXYETHYL)PIPERIDINE-1-CARBOXYLATE
|
170229-04-6
|
C14H27NO4
|
|
4-[4-(Methoxycarbonyl)-2-Methylphenyl]benzoic acid
|
170229-81-9
|
C16H14O4
|
|
4-BROMO-3-METHYLBENZAMIDE
|
170229-98-8
|
C8H8BrNO
|
|
4-(pyridin-2-yl)phenylboronic acid
|
170230-27-0
|
C11H10BNO2
|
|
4-(pyridin-3-yl)phenylboronic acid
|
170230-28-1
|
C11H10BNO2
|
|
4-broMo-3-ethyl-Benzonitrile
|
170230-29-2
|
C9H8BrN
|
|
SB 216641 HYDROCHLORIDE
|
170230-39-4
|
C28H30N4O4
|
|
SB 216641 HYDROCHLORIDE
|
170230-44-1
|
C28H31ClN4O4
|
|
4-AMINO-3-ETHYLBENZONITRILE
|
170230-87-2
|
C9H10N2
|
|
5-Carboxy-2-methylphenylboronicacid
|
170230-88-3
|
C8H9BO4
|
|
5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl acetate
|
170232-37-8
|
C16H11ClFNO2
|
|
2,4-Dibromothiazole-5-methanol
|
170232-68-5
|
C4H3Br2NOS
|
|
2,4-Dichloro-5-thiazolemethanol
|
170232-69-6
|
C4H3Cl2NOS
|
|
Ethanone, 1-(1,4,5,6-tetrahydro-6-hydroxy-1-methyl-3-pyridinyl)- (9CI)
|
170232-97-0
|
C8H13NO2
|
|
3-Pyridinecarboxaldehyde, 1,4,5,6-tetrahydro-6-hydroxy-1-methyl- (9CI)
|
170232-98-1
|
C7H11NO2
|
|
3-Pyridinecarbonitrile,1,4,5,6-tetrahydro-6-hydroxy-1-methyl-(9CI)
|
170232-99-2
|
C7H10N2O
|
|
Pyridine, 2-(2-methyloxiranyl)- (9CI)
|
170233-00-8
|
C8H9NO
|
|
2-Pentyl-3-methyl-5-heptylfuran
|
170233-67-7
|
C17H30O
|
|
Cyclopentanecarboxylic acid, 2-hydroxy-3-methyl-, methyl ester, (1alpha,2beta,3alpha)-
|
170234-09-0
|
C8H14O3
|
|
2-Pyridinecarboxylic acid, 6-broMo-5-Methoxy-, Methyl ester
|
170235-18-4
|
C8H8BrNO3
|
|
methyl 6-bromo-5-hydroxy-2-pyridinecarboxylate
|
170235-19-5
|
C7H6BrNO3
|
|
METHYL 2-BROMOTHIAZOLE-4-CARBOXYLATE
|
170235-26-4
|
C5H4BrNO2S
|
|
Perfluorobutanamide, N-(2-benzoyl-1-phenylethen-1-yl)-
|
170238-81-0
|
C19H12F7NO2
|
|
2-AMINO-5-[1,3]DIOXOLAN-2-YL-PENTANOIC ACID
|
170242-34-9
|
C8H15NO4
|
|
5-Aminomethyl-naphthalen-2-ol
|
170244-98-1
|
C15H15NO2
|
|
MSH-B
|
170245-12-2
|
C107H157N33O29S
|
|
3H-IMIDAZO[4,5-C]PYRIDINE
|
170245-15-5
|
C6H5N3
|
|
3H-IMIDAZO[4,5-B]PYRIDINE
|
170245-18-8
|
C6H5N3
|
|
4H-Imidazo[4,5-b]pyridine(9CI)
|
170245-19-9
|
C6H5N3
|
|
Siloxanes and silicones, 3-[(2-aminoethyl)amino]propyl Me, di-Me, methoxy-terminated, reaction products with polyethylene glycol Bu glycidyl ether
|
170274-77-8
|
|
|
5-Nitro-4-ethoxy-diphenylamine-2-carboxylic acid
|
170274-85-8
|
C15H14N2O5
|
|
N-Benzoyl-p-toluenesulfonamide sodium
|
170275-21-5
|
|
|
Heptyl methyl methylphosphonate
|
170275-60-2
|
C9H21O3P
|
|
Infliximab
|
170277-31-3
|
|
|
(3S)-3-[2-(MESYLOXY)ETHOXY]-4-(TRITYLOXY)BUTYL METHANESULFONATE
|
170277-77-7
|
C27H32O8S2
|
|
N-Succinimidyl 3-(Diphenylphosphino)propionate
|
170278-50-9
|
C19H18NO4P
|
|
Benzaldehyde, 2-fluoro-4,6-dihydroxy- (9CI)
|
170282-90-3
|
C7H5FO3
|
|
Isothiazol-4-ylMethanol
|
170283-02-0
|
C4H5NOS
|
|
2(3H)-Furanone, 3-fluoro-3-(fluoroacetyl)dihydro- (9CI)
|
170283-36-0
|
C6H6F2O3
|